{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:29:23Z","timestamp":1780471763604,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T00:00:00Z","timestamp":1538784000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00228-018-2570-x","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T20:51:26Z","timestamp":1538772686000},"page":"171-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1007","volume":"75","author":[{"given":"Arash","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ghashghai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Yazdani-Charati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Salehifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8055-8036","authenticated-orcid":false,"given":"Seyed Jalal","family":"Hosseinimehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,6]]},"reference":[{"issue":"S3","key":"2570_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7314\/APJCP.2016.17.S3.43","volume":"17","author":"M Ghoncheh","year":"2016","unstructured":"Ghoncheh M, Pournamdar Z, Salehiniya H (2016) Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev 17(S3):43\u201346","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"2570_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893\u20132917. \n                    https:\/\/doi.org\/10.1002\/ijc.25516","journal-title":"Int J Cancer"},{"issue":"14","key":"2570_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1056\/NEJM199710023371401","volume":"337","author":"M Overgaard","year":"1997","unstructured":"Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast Cancer cooperative group 82b trial. N Engl J Med 337(14):949\u2013955. \n                    https:\/\/doi.org\/10.1056\/NEJM199710023371401","journal-title":"N Engl J Med"},{"issue":"10","key":"2570_CR4","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2260::AID-CNCR9>3.0.CO;2-M","volume":"88","author":"TJ Whelan","year":"2000","unstructured":"Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P, Group OCO (2000) The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Cancer 88(10):2260\u20132266","journal-title":"Cancer"},{"issue":"10","key":"2570_CR5","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2260::AID-CNCR9>3.0.CO;2-M","volume":"88","author":"TJ Whelan","year":"2000","unstructured":"Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P (2000) The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer 88(10):2260\u20132266","journal-title":"Cancer"},{"key":"2570_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1748-717X-7-121","volume":"7","author":"RJ Chan","year":"2012","unstructured":"Chan RJ, Keller J, Cheuk R, Blades R, Tripcony L, Keogh S (2012) A double-blind randomised controlled trial of a natural oil-based emulsion (Moogoo Udder Cream\u00ae) containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer. Radiat Oncol 7:121. \n                    https:\/\/doi.org\/10.1186\/1748-717X-7-121","journal-title":"Radiat Oncol"},{"issue":"6","key":"2570_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/00002820-200212000-00007","volume":"25","author":"S Heggie","year":"2002","unstructured":"Heggie S, Bryant GP, Tripcony L, Keller J, Rose P, Glendenning M, Heath J (2002) A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 25(6):442\u2013451","journal-title":"Cancer Nurs"},{"issue":"3","key":"2570_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3857\/roj.2014.32.3.156","volume":"32","author":"HC Kang","year":"2014","unstructured":"Kang HC, Ahn SD, Choi DH, Kang MK, Chung WK, Wu HG (2014) The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study. Radiat Oncol J 32(3):156\u2013162. \n                    https:\/\/doi.org\/10.3857\/roj.2014.32.3.156","journal-title":"Radiat Oncol J"},{"issue":"4","key":"2570_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/0019-509X.29424","volume":"43","author":"PN Shukla","year":"2006","unstructured":"Shukla PN, Gairola M, Mohanti BK, Rath GK (2006) Prophylactic beclomethasone spray to the skin during postoperative radiotherapy of carcinoma breast: a prospective randomized study. Indian J Cancer 43(4):180\u2013184","journal-title":"Indian J Cancer"},{"issue":"2","key":"2570_CR10","first-page":"305","volume":"8","author":"E Fenig","year":"2001","unstructured":"Fenig E, Brenner B, Katz A, Sulkes J, Lapidot M, Schachter J, Malik H, Sulkes A, Gutman H (2001) Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep 8(2):305\u2013309","journal-title":"Oncol Rep"},{"issue":"15","key":"2570_CR11","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.2217\/fon.14.177","volume":"10","author":"SJ Hosseinimehr","year":"2014","unstructured":"Hosseinimehr SJ (2014) The use of angiotensin II receptor antagonists to increase the efficacy of radiotherapy in cancer treatment. Future Oncol 10(15):2381\u20132390. \n                    https:\/\/doi.org\/10.2217\/fon.14.177","journal-title":"Future Oncol"},{"issue":"4","key":"2570_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.drudis.2016.02.019","volume":"21","author":"E Salehifar","year":"2016","unstructured":"Salehifar E, Hosseinimehr SJ (2016) The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers. Drug Discov Today 21(4):654\u2013662. \n                    https:\/\/doi.org\/10.1016\/j.drudis.2016.02.019","journal-title":"Drug Discov Today"},{"issue":"3","key":"2570_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1742-481X.2011.00888.x","volume":"9","author":"S Farsaei","year":"2012","unstructured":"Farsaei S, Khalili H, Farboud ES (2012) Potential role of statins on wound healing: review of the literature. Int Wound J 9(3):238\u2013247. \n                    https:\/\/doi.org\/10.1111\/j.1742-481X.2011.00888.x","journal-title":"Int Wound J"},{"issue":"11","key":"2570_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1365-4632.2010.04579.x","volume":"49","author":"F Jowkar","year":"2010","unstructured":"Jowkar F, Namazi MR (2010) Statins in dermatology. Int J Dermatol 49(11):1235\u20131243. \n                    https:\/\/doi.org\/10.1111\/j.1365-4632.2010.04579.x","journal-title":"Int J Dermatol"},{"issue":"12","key":"2570_CR15","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.intimp.2006.08.006","volume":"6","author":"AG Tristano","year":"2006","unstructured":"Tristano AG, Fuller K (2006) Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved. Int Immunopharmacol 6(12):1833\u20131846. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2006.08.006","journal-title":"Int Immunopharmacol"},{"issue":"2\u20133","key":"2570_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12026-013-8409-8","volume":"56","author":"S Khattri","year":"2013","unstructured":"Khattri S, Zandman-Goddard G (2013) Statins and autoimmunity. Immunol Res 56(2\u20133):348\u2013357. \n                    https:\/\/doi.org\/10.1007\/s12026-013-8409-8","journal-title":"Immunol Res"},{"issue":"6","key":"2570_CR17","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.ajpath.2012.08.023","volume":"181","author":"J Asai","year":"2012","unstructured":"Asai J, Takenaka H, Hirakawa S, Sakabe J, Hagura A, Kishimoto S, Maruyama K, Kajiya K, Kinoshita S, Tokura Y, Katoh N (2012) Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. Am J Pathol 181(6):2217\u20132224. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.023","journal-title":"Am J Pathol"},{"issue":"7","key":"2570_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.2042-7158.2011.01302.x","volume":"63","author":"L Bracht","year":"2011","unstructured":"Bracht L, Caparroz-Assef SM, Magon TF, Ritter AM, Cuman RK, Bersani-Amado CA (2011) Topical anti-inflammatory effect of hypocholesterolaemic drugs. J Pharm Pharmacol 63(7):971\u2013975. \n                    https:\/\/doi.org\/10.1111\/j.2042-7158.2011.01302.x","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"2570_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1099800414537348","volume":"17","author":"VF Suzuki-Banhesse","year":"2015","unstructured":"Suzuki-Banhesse VF, Azevedo FF, Araujo EP, do Amaral ME, Caricilli AM, Saad MJ, Lima MH (2015) Effect of atorvastatin on wound healing in rats. Biol Res Nurs 17(2):159\u2013168. \n                    https:\/\/doi.org\/10.1177\/1099800414537348","journal-title":"Biol Res Nurs"},{"issue":"1","key":"2570_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbrc.2004.07.087","volume":"322","author":"O Soehnlein","year":"2004","unstructured":"Soehnlein O, Eskafi S, Schmeisser A, Kloos H, Daniel WG, Garlichs CD (2004) Atorvastatin induces tissue transglutaminase in human endothelial cells. Biochem Biophys Res Commun 322(1):105\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2004.07.087","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2570_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0021-9150(00)00454-8","volume":"152","author":"S Lopez","year":"2000","unstructured":"Lopez S, Peiretti F, Bonardo B, Juhan-Vague I, Nalbone G (2000) Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 152(2):359\u2013366","journal-title":"Atherosclerosis"},{"issue":"8","key":"2570_CR22","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00701-010-0652-3","volume":"152","author":"CZ Chang","year":"2010","unstructured":"Chang CZ, Wu SC, Lin CL, Hwang SL, Howng SL, Kwan AL (2010) Atorvastatin preconditioning attenuates the production of endothelin-1 and prevents experimental vasospasm in rats. Acta Neurochir 152(8):1399\u20131406; discussion 1405-1396. \n                    https:\/\/doi.org\/10.1007\/s00701-010-0652-3","journal-title":"Acta Neurochir"},{"issue":"6","key":"2570_CR23","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s10753-013-9688-x","volume":"36","author":"NN Pathak","year":"2013","unstructured":"Pathak NN, Balaganur V, Lingaraju MC, More AS, Kant V, Kumar D, Kumar D, Tandan SK (2013) Antihyperalgesic and anti-inflammatory effects of atorvastatin in chronic constriction injury-induced neuropathic pain in rats. Inflammation 36(6):1468\u20131478. \n                    https:\/\/doi.org\/10.1007\/s10753-013-9688-x","journal-title":"Inflammation"},{"issue":"4","key":"2570_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10787-010-0044-6","volume":"18","author":"MM Ghaisas","year":"2010","unstructured":"Ghaisas MM, Dandawate PR, Zawar SA, Ahire YS, Gandhi SP (2010) Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models. Inflammopharmacology 18(4):169\u2013177. \n                    https:\/\/doi.org\/10.1007\/s10787-010-0044-6","journal-title":"Inflammopharmacology"},{"issue":"1","key":"2570_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/phar.1339","volume":"34","author":"S Farsaei","year":"2014","unstructured":"Farsaei S, Khalili H, Farboud ES, Karimzadeh I, Beigmohammadi MT (2014) Efficacy of topical atorvastatin for the treatment of pressure ulcers: a randomized clinical trial. Pharmacotherapy 34(1):19\u201327. \n                    https:\/\/doi.org\/10.1002\/phar.1339","journal-title":"Pharmacotherapy"},{"issue":"3","key":"2570_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/MAJ.0b013e3181aaf209","volume":"338","author":"S Toker","year":"2009","unstructured":"Toker S, Gulcan E, Cayc MK, Olgun EG, Erbilen E, Ozay Y (2009) Topical atorvastatin in the treatment of diabetic wounds. Am J Med Sci 338(3):201\u2013204. \n                    https:\/\/doi.org\/10.1097\/MAJ.0b013e3181aaf209","journal-title":"Am J Med Sci"},{"issue":"3","key":"2570_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ijrobp.2012.06.042","volume":"85","author":"G Jacobson","year":"2013","unstructured":"Jacobson G, Bhatia S, Smith BJ, Button AM, Bodeker K, Buatti J (2013) Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter. Int J Radiat Oncol Biol Phys 85(3):604\u2013608. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2012.06.042","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2570_CR28","doi-asserted-by":"publisher","unstructured":"Rao S, Hegde SK, Baliga-Rao MP, Lobo J, Palatty PL, George T, Baliga MS (2017) Sandalwood oil and turmeric-based cream prevents ionizing radiation-induced dermatitis in breast cancer patients: clinical study. Medicines (Basel) 4(3) \n                    https:\/\/doi.org\/10.3390\/medicines4030043","DOI":"10.3390\/medicines4030043"},{"issue":"5","key":"2570_CR29","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"2570_CR30","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/0360-3016(85)90029-X","volume":"11","author":"RD Pezner","year":"1985","unstructured":"Pezner RD, Patterson MP, Hill LR, Desai KR, Vora N, Lipsett JA (1985) Breast edema in patients treated conservatively for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 11(10):1765\u20131768","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2570_CR31","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ijrobp.2007.02.044","volume":"68","author":"A Harsolia","year":"2007","unstructured":"Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C, Lala M, Martinez A, Schell S, Vicini FA (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68(5):1375\u20131380. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2007.02.044","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2570_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/01.coc.0000138965.97476.0f","volume":"27","author":"E Berthelet","year":"2004","unstructured":"Berthelet E, Truong PT, Musso K, Grant V, Kwan W, Moravan V, Patterson K, Olivotto IA (2004) Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy. Am J Clin Oncol 27(6):626\u2013631","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"2570_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ijrobp.2008.08.071","volume":"74","author":"GM Freedman","year":"2009","unstructured":"Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC, Anderson PR (2009) Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 74(3):689\u2013694. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2008.08.071","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2570_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/tbj.12206","volume":"20","author":"A Zygogianni","year":"2014","unstructured":"Zygogianni A, Kouloulias V, Antypas C, Armpilia C, Kyrgias G, Kouvaris J (2014) The impact of intermediate time between chemotherapy and hypofractionated radiotherapy to the radiation induced skin toxicity for breast adjuvant treatment. Breast J 20(1):74\u201378. \n                    https:\/\/doi.org\/10.1111\/tbj.12206","journal-title":"Breast J"},{"key":"2570_CR35","doi-asserted-by":"publisher","unstructured":"James ML, Lehman M, Hider PN, Jeffery M, Francis DP, Hickey BE (2008) Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database Syst Rev (3): CD003860. \n                    https:\/\/doi.org\/10.1002\/14651858.CD003860.pub2","DOI":"10.1002\/14651858.CD003860.pub2"},{"issue":"10","key":"2570_CR36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/01.SMJ.0000140866.97278.87","volume":"97","author":"JL Harper","year":"2004","unstructured":"Harper JL, Franklin LE, Jenrette JM, Aguero EG (2004) Skin toxicity during breast irradiation: pathophysiology and management. South Med J 97(10):989\u2013993. \n                    https:\/\/doi.org\/10.1097\/01.SMJ.0000140866.97278.87","journal-title":"South Med J"},{"issue":"1","key":"2570_CR37","first-page":"68","volume":"61","author":"SJ Hosseinimehr","year":"2015","unstructured":"Hosseinimehr SJ, Izakmehri M, Ghasemi A (2015) In vitro protective effect of atorvastatin against ionizing radiation induced genotoxicity in human lymphocytes. Cell Mol Biol (Noisy-le-grand) 61(1):68\u201371","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"151","key":"2570_CR38","first-page":"1","volume":"27","author":"M Hamzeh","year":"2017","unstructured":"Hamzeh M, Talebpour Amiri F, Karimpour Malekshah A, Yaghubi Beklar S, Hosseinimehr J (2017) Protective effect of atorvastatin against cardiotoxicity and hematotoxicity induced by cyclophosphamide in rat. J Mazand Univ Med Sci 27(151):1\u201311","journal-title":"J Mazand Univ Med Sci"},{"issue":"2","key":"2570_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/09553002.2018.1420926","volume":"94","author":"F Talebpour Amiri","year":"2018","unstructured":"Talebpour Amiri F, Hamzeh M, Naeimi RA, Ghasemi A, Hosseinimehr SJ (2018) Radioprotective effect of atorvastatin against ionizing radiation-induced nephrotoxicity in mice. Int J Radiat Biol 94(2):106\u2013113. \n                    https:\/\/doi.org\/10.1080\/09553002.2018.1420926","journal-title":"Int J Radiat Biol"},{"key":"2570_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.reprotox.2017.06.052","volume":"72","author":"RA Naeimi","year":"2017","unstructured":"Naeimi RA, Talebpour Amiri F, Khalatbary AR, Ghasemi A, Zargari M, Ghesemi M, Hosseinimehr SJ (2017) Atorvastatin mitigates testicular injuries induced by ionizing radiation in mice. Reprod Toxicol 72:115\u2013121. \n                    https:\/\/doi.org\/10.1016\/j.reprotox.2017.06.052","journal-title":"Reprod Toxicol"},{"issue":"10","key":"2570_CR41","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.clon.2011.04.011","volume":"23","author":"GC Barnett","year":"2011","unstructured":"Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE (2011) The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity. Clin Oncol (R Coll Radiol) 23(10):662\u2013673. \n                    https:\/\/doi.org\/10.1016\/j.clon.2011.04.011","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"2570_CR42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10549-014-3110-8","volume":"147","author":"H Verbelen","year":"2014","unstructured":"Verbelen H, Gebruers N, Beyers T, De Monie AC, Tjalma W (2014) Breast edema in breast cancer patients following breast-conserving surgery and radiotherapy: a systematic review. Breast Cancer Res Treat 147(3):463\u2013471. \n                    https:\/\/doi.org\/10.1007\/s10549-014-3110-8","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2570_CR43","first-page":"154","volume":"45","author":"N Adriaenssens","year":"2012","unstructured":"Adriaenssens N, Verbelen H, Lievens P, Lamote J (2012) Lymphedema of the operated and irradiated breast in breast cancer patients following breast conserving surgery and radiotherapy. Lymphology 45(4):154\u2013164","journal-title":"Lymphology"},{"issue":"3","key":"2570_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.pec.2007.01.004","volume":"66","author":"HA Bani","year":"2007","unstructured":"Bani HA, Fasching PA, Lux MM, Rauh C, Willner M, Eder I, Loehberg C, Schrauder M, Beckmann MW, Bani MR (2007) Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit. Patient Educ Couns 66(3):311\u2013318. \n                    https:\/\/doi.org\/10.1016\/j.pec.2007.01.004","journal-title":"Patient Educ Couns"},{"issue":"7","key":"2570_CR45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/ars.2011.4145","volume":"16","author":"Z Huang","year":"2012","unstructured":"Huang Z, Rose AH, Hoffmann PR (2012) The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 16(7):705\u2013743. \n                    https:\/\/doi.org\/10.1089\/ars.2011.4145","journal-title":"Antioxid Redox Signal"},{"key":"2570_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jtemb.2016.05.005","volume":"37","author":"C Pfister","year":"2016","unstructured":"Pfister C, Dawzcynski H, Schingale FJ (2016) Sodium selenite and cancer related lymphedema: biological and pharmacological effects. J Trace Elem Med Biol 37:111\u2013116. \n                    https:\/\/doi.org\/10.1016\/j.jtemb.2016.05.005","journal-title":"J Trace Elem Med Biol"},{"issue":"6","key":"2570_CR47","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s12272-014-0496-0","volume":"38","author":"NM Kulkarni","year":"2015","unstructured":"Kulkarni NM, Muley MM, Jaji MS, Vijaykanth G, Raghul J, Reddy NK, Vishwakarma SL, Rajesh NB, Mookkan J, Krishnan UM, Narayanan S (2015) Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-kappaB activation. Arch Pharm Res 38(6):1238\u20131247. \n                    https:\/\/doi.org\/10.1007\/s12272-014-0496-0","journal-title":"Arch Pharm Res"},{"issue":"5","key":"2570_CR48","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00210-015-1100-y","volume":"388","author":"CC McGown","year":"2015","unstructured":"McGown CC, Brookes ZL, Hellewell PG, Ross JJ, Brown NJ (2015) Atorvastatin reduces endotoxin-induced microvascular inflammation via NOSII. Naunyn Schmiedeberg's Arch Pharmacol 388(5):557\u2013564. \n                    https:\/\/doi.org\/10.1007\/s00210-015-1100-y","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"2\u20133","key":"2570_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0014-2999(95)00575-7","volume":"294","author":"D Kindgen-Milles","year":"1995","unstructured":"Kindgen-Milles D (1995) Effects of prostaglandin E2 on the intensity of bradykinin-evoked pain from skin and veins of humans. Eur J Pharmacol 294(2\u20133):491\u2013496","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2570_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1124\/jpet.107.126045","volume":"324","author":"MH Napimoga","year":"2008","unstructured":"Napimoga MH, Souza GR, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri WA Jr, Cunha FQ, Ferreira SH (2008) 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. J Pharmacol Exp Ther 324(1):313\u2013321. \n                    https:\/\/doi.org\/10.1124\/jpet.107.126045","journal-title":"J Pharmacol Exp Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2570-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2570-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T19:20:49Z","timestamp":1570303249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2570-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2570"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2570-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,6]]},"assertion":[{"value":"30 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they\u00a0had no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest statement"}}]}}